Trial Profile
A RANDOMISED, OPEN-LABEL CLINICAL TRIAL TO ASSESS CERTAIN METABOLIC SIDE EFFECTS OF NOVEL ATYPICAL ANTIPSYCHOTICS - BLONANSERIN IN COMPARISON WITH AMISULPRIDE,IN PERSONS WITH PSYCHOSIS.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Blonanserin (Primary) ; Amisulpride
- Indications Psychotic disorders
- Focus Adverse reactions
- 25 Jan 2013 New trial record